Why Testosterone Cypionate Causes Fertility Suppression: The Mechanism Explained

Q: How quickly does testosterone cypionate reduce sperm count?

Measurable sperm count declines typically begin within 6 to 8 weeks of starting TRT. Most men reach azoospermia or severe oligospermia by 12 to 16 weeks. The delay reflects the 74-day maturation timeline of spermatogenesis, not a slow suppression of LH and FSH, which fall within the first few weeks.

Q: Can I still get someone pregnant while on testosterone cypionate?

Some men retain low but non-zero sperm counts during TRT, so pregnancy is not impossible, but the probability is substantially reduced. Relying on TRT as contraception is not clinically appropriate because suppression is incomplete in a meaningful minority of men. If pregnancy must be avoided, additional contraception is needed.

Q: Will my fertility come back after stopping testosterone cypionate?

For most men, yes. The majority recover to pre-treatment sperm parameters within 6 to 12 months of stopping. A minority, particularly those who used TRT for many years or who had underlying fertility issues, may take up to 24 months or may not fully recover. Baseline semen analysis before starting TRT helps establish what "normal" looks like for a given patient.

Q: Does the dose or injection frequency of testosterone cypionate affect how much fertility suppression occurs?

Higher doses and more frequent injections produce deeper and more sustained LH and FSH suppression. However, even doses at the lower end of the therapeutic range reliably suppress gonadotropins enough to cause clinically significant sperm count reductions. There is no dose of testosterone cypionate that avoids HPG axis suppression entirely.

Q: What is intratesticular testosterone and why does it matter for fertility?

Intratesticular testosterone is the concentration of testosterone inside the testes themselves. It runs 50, 100 times higher than serum levels under normal conditions, and spermatogenesis depends on that high local concentration. Exogenous testosterone raises serum levels but collapses ITT because it eliminates the LH signal that drives local testicular testosterone production.

Q: Can I take hCG alongside testosterone cypionate to protect my fertility?

Yes. hCG mimics LH and can partially maintain intratesticular testosterone production even when pituitary LH is suppressed by exogenous testosterone. Studies support doses of 250 to 500 IU two to three times per week as sufficient to preserve ITT and reduce, though not always eliminate, spermatogenic suppression. This approach requires monitoring and should be managed by a physician familiar with both TRT and reproductive endocrinology.

Q: Should I bank sperm before starting testosterone cypionate?

Yes, if you have not completed family planning. Sperm cryopreservation before the first injection is the most reliable fertility preservation strategy available. It removes uncertainty about recovery and is straightforward to arrange through a urology or reproductive medicine clinic.

Q: Does testosterone gel or other forms of TRT affect fertility differently than injections?

All exogenous testosterone formulations suppress the HPG axis through the same negative feedback mechanism. The degree of LH and FSH suppression depends on how much free testosterone reaches systemic circulation, not on the delivery method. Topical gels applied at standard doses produce equivalent gonadotropin suppression to injectable forms, though the pharmacokinetic profile differs.

Q: My doctor says my testosterone levels are normal on TRT. Why is my sperm count still zero?

Serum testosterone and sperm production are regulated by different mechanisms. Normal serum testosterone on TRT reflects the exogenous drug working as intended. Zero sperm count reflects the fact that pituitary LH is suppressed, intratesticular testosterone has collapsed, and spermatogenesis has stalled. These findings are entirely compatible with each other and do not indicate a separate problem.

Q: How long should I wait after stopping TRT before trying to conceive?

Most clinicians recommend waiting at least three to six months after stopping testosterone cypionate before attempting conception and confirming recovery with a semen analysis. If the count remains severely suppressed at 12 months, a reproductive urologist should be involved. Attempting conception before confirming sperm recovery is often unsuccessful and delays diagnosis of incomplete recovery.

By HealthRX.com Medical Team

Updated Jul 14, 2025

Image: HealthRX.com AI-generated clinical image

Why Testosterone Cypionate Causes Fertility Suppression: The Mechanism Explained

At a glance

Incidence of azoospermia or severe oligospermia: 65 to 90% of men on standard TRT doses within 3 to 6 months, based on WHO-sponsored contraceptive trials using testosterone esters
Onset of sperm count decline: Measurable suppression begins within 4 to 6 weeks; clinical azoospermia typically by 12 to 16 weeks
First-line fertility preservation: Stop testosterone cypionate before attempting conception; discuss sperm banking before starting TRT
Adjunct options during TRT: Human chorionic gonadotropin (hCG) co-administration to maintain intratesticular testosterone and partial spermatogenesis
Recovery timeline: Median return to baseline sperm parameters is 3 to 6 months after stopping; full recovery can take 12 to 24 months in some patients
When to escalate: No sperm recovery after 24 months off TRT warrants full urologic and endocrine evaluation
When to discontinue: Any patient who desires fertility should be counseled to discontinue or switch protocols well before attempting conception

The Hypothalamic-Pituitary-Gonadal Axis: What TRT Is Actually Overriding

The body regulates testosterone through a closed-loop feedback system called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in short, pulsatile bursts every 60 to 90 minutes. Each pulse prompts the anterior pituitary to secrete two gonadotropins: luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

LH acts on testicular Leydig cells to drive local testosterone synthesis. FSH acts on Sertoli cells to support the physical architecture of spermatogenesis. Critically, intratesticular testosterone concentrations are 50 to 100 times higher than serum levels, and that steep local gradient is what sperm maturation actually requires. Serum testosterone, no matter how strong, cannot replicate it.

When the hypothalamus and pituitary detect adequate circulating testosterone, GnRH pulse frequency decreases, LH and FSH secretion falls, and Leydig cell output drops. This is the normal negative feedback loop at work. Testosterone Cypionate exploits exactly that loop.

How Testosterone Cypionate Dismantles the Loop

Testosterone Cypionate is an esterified form of testosterone with a cypionate ester attached at the 17-beta hydroxyl position. After intramuscular injection, esterases in serum and tissue cleave the ester bond, releasing free testosterone over roughly 7 to 10 days. This produces a prolonged supraphysiological peak followed by a gradual decline, but across an entire treatment cycle the hypothalamus and pituitary are exposed to testosterone concentrations well above the set-point at which they suppress their own output.

The hypothalamus interprets persistent high circulating testosterone as evidence that the testes are overproducing and responds by reducing GnRH pulse amplitude and frequency. The pituitary, receiving fewer and weaker GnRH signals, cuts LH and FSH secretion. Studies measuring gonadotropin levels in men on exogenous testosterone consistently find LH suppression to <1 IU/L within four to six weeks of initiating therapy. FSH, which has a longer half-life, takes slightly longer but typically reaches similarly suppressed levels by 8 to 12 weeks.

The WHO multicenter contraceptive trial demonstrated that weekly intramuscular testosterone enanthate (a closely related ester) suppressed sperm counts to azoospermia in approximately 65% of participants and to severe oligospermia (<3 million/mL) in most of the remainder, all within six months. Testosterone Cypionate produces equivalent pharmacodynamic effects at comparable doses.

The Intratesticular Testosterone Problem

This is the part most patients never hear explained clearly. Serum testosterone on TRT is often well within or above the normal reference range. So why does sperm production fail?

The answer is that spermatogenesis does not run on serum testosterone. It runs on intratesticular testosterone (ITT), the concentration inside the seminiferous tubules themselves. ITT is generated locally by Leydig cells responding to LH. When LH disappears because exogenous testosterone has suppressed the pituitary, Leydig cells go quiet. ITT collapses to roughly 1 to 2% of its normal value, even while serum testosterone remains high.

Sertoli cells, which physically support developing sperm cells through every stage of maturation, require sustained high-ITT exposure to function. Without it, the spermatogenic epithelium undergoes progressive vacuolization. Spermatogonial differentiation slows, then stops. Sperm output in the ejaculate falls over the following 10 to 16 weeks as the population of cells that were already in the pipeline finishes maturing and is not replaced.

The clinical result is that a man can have a serum testosterone of 700 to 1000 ng/dL and a sperm count of zero. These two measurements are not contradictory; they reflect two entirely separate hormonal compartments operating under different regulatory inputs.

Timeline of Suppression: What the Data Show

Spermatogenesis is a slow process. From spermatogonial stem cell to mature spermatozoon takes approximately 74 days in humans, with an additional 12 to 21 days of epididymal transit. This means the effects of gonadotropin suppression are not immediately visible in semen analysis.

In practice, studies tracking semen parameters during testosterone treatment show:

Weeks 1, 4: LH and FSH suppress. ITT begins declining. No visible change in sperm count yet.
Weeks 4, 8: The cohort of sperm cells that had started development before LH suppression continues maturing. Sperm counts may drop only modestly.
Weeks 8, 16: As pre-suppression cohorts are exhausted, counts fall sharply. Most men reach azoospermia or severe oligospermia in this window.
Beyond 16 weeks: Sustained azoospermia in the majority of treated men. Sertoli cell function remains blunted as long as LH and FSH are suppressed.

This 12 to 16 week window explains why TRT has been studied as a male contraceptive and why clinicians should treat fertility suppression as an expected pharmacological effect, not an idiosyncratic complication.

Why Some Men Recover Faster Than Others

Recovery of spermatogenesis after stopping Testosterone Cypionate depends on how quickly the HPG axis restores normal GnRH pulsatility and gonadotropin secretion. Several factors influence that timeline.

Duration of TRT is the most clinically significant variable. A systematic review by Liu et al. found that men who used testosterone for longer periods had slower and less complete recovery, though the majority of men did eventually recover. Men on TRT for more than three years showed the slowest restoration of sperm parameters.

Age matters because baseline pituitary reserve and testicular function decline over time. Older men may have a blunted gonadotropin rebound after TRT cessation.

Pre-existing fertility issues will not be corrected by stopping TRT. If a man had oligospermia before starting treatment, he may remain oligospermic after recovery even if the TRT effect fully reverses.

Body composition also has a minor role. Adipose tissue aromatizes testosterone to estradiol, and elevated estradiol independently suppresses the HPG axis. Men with significant adiposity may have a more prolonged recovery because elevated estradiol continues to blunt GnRH pulsatility even after exogenous testosterone is cleared.

Preserving Fertility While on TRT: The hCG Strategy

For men who want to remain on TRT but preserve some sperm production capacity, co-administration of human chorionic gonadotropin (hCG) is the best-studied strategy. hCG is a structural analog of LH. Injected subcutaneously two to three times per week, it binds directly to Leydig cell LH receptors and drives local testosterone synthesis independent of pituitary output.

Studies using doses of 250 to 500 IU hCG two to three times weekly alongside exogenous testosterone have shown that ITT can be maintained at levels sufficient to preserve partial spermatogenesis in most men. Sperm counts may not reach normal ranges, but azoospermia is often avoided. This approach is most relevant for men who are not currently trying to conceive but want to maintain future fertility options while continuing TRT.

Clomiphene citrate and selective estrogen receptor modulators are sometimes used post-TRT to accelerate HPG axis recovery, though evidence for their efficacy in this context is more limited and primarily drawn from hypogonadism recovery protocols rather than randomized fertility trials.

What Patients Should Do Before Starting TRT

The single most consequential fertility preservation step is sperm banking before the first injection. Cryopreserved sperm provides a reliable fallback regardless of how recovery proceeds. Any man of reproductive age who has not completed family planning should be offered this option explicitly before testosterone therapy begins. This recommendation is consistent with guidance from the American Urological Association and the Endocrine Society.

If a patient is already on TRT and wishes to conceive, the practical steps are: stop testosterone cypionate, wait for gonadotropin recovery (typically 3 to 6 months), obtain serial semen analyses starting at three months off therapy, and consult a reproductive urologist if counts remain severely suppressed at 12 months.

Frequently asked questions

How quickly does testosterone cypionate reduce sperm count?

Measurable sperm count declines typically begin within 6 to 8 weeks of starting TRT. Most men reach azoospermia or severe oligospermia by 12 to 16 weeks. The delay reflects the 74-day maturation timeline of spermatogenesis, not a slow suppression of LH and FSH, which fall within the first few weeks.

Can I still get someone pregnant while on testosterone cypionate?

Some men retain low but non-zero sperm counts during TRT, so pregnancy is not impossible, but the probability is substantially reduced. Relying on TRT as contraception is not clinically appropriate because suppression is incomplete in a meaningful minority of men. If pregnancy must be avoided, additional contraception is needed.

Will my fertility come back after stopping testosterone cypionate?

For most men, yes. The majority recover to pre-treatment sperm parameters within 6 to 12 months of stopping. A minority, particularly those who used TRT for many years or who had underlying fertility issues, may take up to 24 months or may not fully recover. Baseline semen analysis before starting TRT helps establish what "normal" looks like for a given patient.

Does the dose or injection frequency of testosterone cypionate affect how much fertility suppression occurs?

Higher doses and more frequent injections produce deeper and more sustained LH and FSH suppression. However, even doses at the lower end of the therapeutic range reliably suppress gonadotropins enough to cause clinically significant sperm count reductions. There is no dose of testosterone cypionate that avoids HPG axis suppression entirely.

What is intratesticular testosterone and why does it matter for fertility?

Intratesticular testosterone is the concentration of testosterone inside the testes themselves. It runs 50, 100 times higher than serum levels under normal conditions, and spermatogenesis depends on that high local concentration. Exogenous testosterone raises serum levels but collapses ITT because it eliminates the LH signal that drives local testicular testosterone production.

Can I take hCG alongside testosterone cypionate to protect my fertility?

Yes. hCG mimics LH and can partially maintain intratesticular testosterone production even when pituitary LH is suppressed by exogenous testosterone. Studies support doses of 250 to 500 IU two to three times per week as sufficient to preserve ITT and reduce, though not always eliminate, spermatogenic suppression. This approach requires monitoring and should be managed by a physician familiar with both TRT and reproductive endocrinology.

Should I bank sperm before starting testosterone cypionate?

Yes, if you have not completed family planning. Sperm cryopreservation before the first injection is the most reliable fertility preservation strategy available. It removes uncertainty about recovery and is straightforward to arrange through a urology or reproductive medicine clinic.

Does testosterone gel or other forms of TRT affect fertility differently than injections?

All exogenous testosterone formulations suppress the HPG axis through the same negative feedback mechanism. The degree of LH and FSH suppression depends on how much free testosterone reaches systemic circulation, not on the delivery method. Topical gels applied at standard doses produce equivalent gonadotropin suppression to injectable forms, though the pharmacokinetic profile differs.

My doctor says my testosterone levels are normal on TRT. Why is my sperm count still zero?

Serum testosterone and sperm production are regulated by different mechanisms. Normal serum testosterone on TRT reflects the exogenous drug working as intended. Zero sperm count reflects the fact that pituitary LH is suppressed, intratesticular testosterone has collapsed, and spermatogenesis has stalled. These findings are entirely compatible with each other and do not indicate a separate problem.

How long should I wait after stopping TRT before trying to conceive?

Most clinicians recommend waiting at least three to six months after stopping testosterone cypionate before attempting conception and confirming recovery with a semen analysis. If the count remains severely suppressed at 12 months, a reproductive urologist should be involved. Attempting conception before confirming sperm recovery is often unsuccessful and delays diagnosis of incomplete recovery.

References

World Health Organization Task Force on Methods for the Regulation of Male Fertility. "Contraceptive efficacy of testosterone-induced azoospermia in normal men." Lancet. 1990;336(8721):955, 959. PubMed
Coviello AD, Matsumoto AM, Bremner WJ, et al. "Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression." Journal of Clinical Endocrinology and Metabolism. 2005;90(5):2595, 2602. PMC
Jarow JP, Lipshultz LI. "Anabolic steroid-induced hypogonadotropic hypogonadism." American Journal of Sports Medicine. 1990;18(4):429, 431. PubMed
Liu PY, Swerdloff RS, Veldhuis JD. "The rationale, efficacy and safety of androgen therapy in older men: Future research and current practice recommendations." Journal of Clinical Endocrinology and Metabolism. 2004;89(10):4789, 4796. PubMed
Mancini A, Milardi D, Conte G, et al. "Intratesticular testosterone: Mechanisms, physiology, and clinical relevance." Journal of Endocrinology. 2013. PMC
Krzastek SC, Sharma D, Abdullah N, et al. "Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism." Journal of Urology. 2019;202(5):1029, 1035. PubMed
American Urological Association. Male Infertility Guideline. AUA; 2021. AUA Guidelines
Bhasin S, Brito JP, Cunningham GR, et al. "Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline." Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1715, 1744. PubMed